We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Standard Life | LSE:SL. | London | Ordinary Share | GB00BVFD7Q58 | ORD 12 2/9P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 410.80 | 413.60 | 413.70 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/1/2017 21:55 | From the info above it could be that we do not see an increase in the dividend this year. That won't please some posters on this board who hold here for dividend growth. Nevertheless I'm happy to hold here and believe that we will see a share price of £4 by the end of the year. I also think that Brexit concerns are also holding back the share price | underhill2 | |
24/1/2017 20:20 | Now the good news. Goldman Sachs Group raised Standard Life Plc's price target from £3.65 ($4.56) to £3.70 ($4.62). They now have a "neutral" rating on the stock. | petewy | |
24/1/2017 18:52 | ADVFN Evening Euro Markets Bulletin : Standard Life retreated after UBS downgraded the stock to 'sell' from 'neutral' and cut the price target to 310p from 320p. "Our rating is driven by our expectation for earnings pressure to emerge in Standard Life Investments in 2017 resulting from increased asset outflows from its flagship £42bn GARS fund. UBS downgraded Standard Life to 'sell' from 'neutral' and lowered its price target to 310p from 320p on expected earnings pressures from increased outflows from Standard Life Investments. The Swiss bank changed its rating on its expectation that earnings pressure will emerge in 2017 on SLI due to increased asset outflows from its flagship £42bn Global Absolute Return Strategies (GARS) fund, which is sold on its aim to provide positive investment returns in all market conditions over the medium to long term. The insurer's share performance is strongly linked to flows and performance of GARS but the fourth quarter of 2016 is estimated to see net outflows increase to around £3bn (including a large UK outflow) compared to the £1.5bn the the third quarter last year. According to UBS analysts GARS outflows are being particularly caused by structural trends that will be difficult to reverse at least in the near-term. This includes current performance below its benchmark, fund size constraining scope for longer-term investment outperformance, pension consultants putting the fund on 'watch' and risks to industry multi-asset flows which could fall toward 2013 levels potentially. The total forecasted multi-asset outflows are £3.9bn for the full year 2016 and £6bn over the full year 2017 resulting in earnings growth of 4%, which is half that of consensus. The bank expects good progress on costs but feels falling revenue will put pressure on ratios. UBS is however positive on asset growth of 8% per annum to 2018 for UK Life and that the company's 24.1% stake in merged HDFC Life and Max Life could be a source of upside over the medium term. The earnings per share estimates for 2017 fell by 9% to 27.28p. | samwn1 | |
24/1/2017 17:22 | UBS downgraded Standard Life today. | wilky58 | |
24/1/2017 11:00 | There must be good reasons for these large daily falls.I would rather have an increasing share price than nice dividends. | underhill2 | |
24/1/2017 09:43 | Nearly back to my break even price....oh well divi will help. | chesty1 | |
18/1/2017 14:03 | Results in 5 weeks. I Think this will start to motor by the end of January.At least that is what I hope! | fidra | |
18/1/2017 11:05 | Needs a broker's buy note | petewy | |
16/1/2017 14:54 | Agree great dividend if it falls much lower i will add some more. | spcecks | |
16/1/2017 13:16 | Blimey 370 looks a long way off all of a sudden, good job we get a great divi. | chesty1 | |
12/1/2017 14:22 | All the way to 4.50 | uppompeii | |
12/1/2017 13:50 | Nice reversal, let's hope it holds | rathlindri | |
11/1/2017 15:28 | Yes, fall seems overdone given strength of market. Full year results not that far away and will hopefully give us a boost. | its the oxman | |
11/1/2017 13:30 | Why is this dropping daily I was looking forward to hitting £4... oh well bring on the divi. | chesty1 | |
05/1/2017 18:00 | MM games before the big rise I should think, inv H&S chart reinforced. My Forecast 470 within 6 mths | big7ime | |
05/1/2017 17:19 | I bought at 363 and 366, not that that means anything at all. | uppompeii | |
05/1/2017 16:06 | Digital Look has an explanation, saying that SL wasn't rated, which I take to mean that no critique was given either way. | waddy | |
05/1/2017 16:05 | Thanks for the replies and info | rathlindri | |
05/1/2017 16:02 | Life sector as a whole is in a downtrend today | dmf | |
05/1/2017 15:57 | It's a serious fall for a FTSE 100 company on the back of a downgrade on another body. | f1araway | |
05/1/2017 15:57 | Normally a short, sharp fall like this is a broker downgrade. Typically they make a recovery pretty quickly. Also works in reverse. I've just opened an sb@363 - only £25pp - hoping to get 371 before my stop loss (351) | dr biotech | |
05/1/2017 15:45 | Downgrade on RSA today, perhaps doing the damage. PRU weak too JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT') | shoee62 | |
05/1/2017 15:45 | Blimey, anyone know why the big fall today? | rathlindri | |
05/1/2017 15:10 | Happy to add?You could have added cheaper 3 weeks ago. | f1araway |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions